429 filings
Page 9 of 22
8-K
8ppwydzyq
28 Jan 20
Other Events
4:24pm
8-K
lhzor0 spy
9 Jan 20
Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
12:00am
8-K
6i4pb80w7qr54w
6 Jan 20
Hepion Pharmaceuticals Announces Publication inExpert Opinion on Investigational Drugs
4:23pm
8-K
oti7y96en
11 Dec 19
Other Events
1:26pm
8-K
1ob7h790j0ntc2
4 Dec 19
Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments
12:00am
8-K
ahaqz1c
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
wura 0c1vqxcfhhlt
20 Nov 19
Other Events
9:27pm
8-K
mulx14z2hp 3xtv
8 Nov 19
Hepion Pharmaceuticals to Present at The Liver MeetingÒ 2019
12:00am
8-K
jpuf6
7 Nov 19
Other Events
12:55pm
8-K
bziqdx0xbov2yzy
23 Oct 19
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit
4:29pm
S-8
lvyon67
21 Oct 19
Registration of securities for employees
4:26pm
8-K
fr4e904n t3xnovdcud
16 Oct 19
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431’s Potential as a Treatment for Chronic Liver Diseases
4:54pm
8-K
fxdav63tur2 5lgc0
10 Oct 19
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director
11:33am
8-K
87n9gijo3za78 omzvfj
8 Oct 19
Departure of Directors or Certain Officers
4:15pm
8-K
x3a82q05d gnl
3 Oct 19
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions
4:20pm
8-K
2yhr7 4mc
4 Sep 19
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
11:46am
8-K
fb3s7m zv8t
3 Sep 19
Other Events
4:39pm
8-K
y9udiqouqu7k m4ze8
14 Aug 19
Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431
12:00am